job cuts news from FiercePharma
News
J&J laying off 400 in marketing overhaul
With Procrit under siege, Johnson & Johnson wants to divert its promotional efforts elsewhere--a strategy that will lead to some 400 job cuts in its sales-and-marketing ranks. The company told Read more...
SPOTLIGHT: GSK axes 430 in England, Ireland
GlaxoSmithKline is following through with its job cuts, with 100 Read more...
Wyeth disputes discrimination claims
Some time back, Wyeth's Pearl River, NY, facility spawned seven discrimination lawsuits. Current and former employees alleged that the company discriminated against them because they're black. Now, Read more...
BMS offloads imaging unit for $525M
Bristol-Myers Squibb said it was going to retrench, and so it is. The company announced this morning that it would sell Read more...
CEO: Novartis plans big restructuring
On second thought, let's restructure the whole company: In October, Novartis announced some job cuts and management changes. Now, Read more...
Behind the scenes of GSK's overhaul
Outgoing GlaxoSmithKline CEO Jean-Paul Garnier is shouldering the heavy load of layoffs and restructuring to give his successor Andrew Witty (Read more...
Bristol CEO: Job cuts, shutdowns continue
It's a layoffs kind of news day. Bristol-Myers Squibb CEO James Cornelius announced that job cuts have begun at the drug maker, and will continue through year's end and into 2008. Facilities will be Read more...
J&J job cuts hit Belgian subsidiary
Johnson & Johnson's restructuring has come home to roost in Belgium. Drug maker Janssen-Cilag, a J&J subsidiary, will slice 521 full-time and 167 part-time workers from its payroll of 4,723 Read more...
FDA: 2,000 layoffs if PDUFA not passed
It appears that the FDA Commissioner is playing an indirect game of "chicken" with Congress. Friday, Andrew von Eschenbach (Read more...
Get more job cuts coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends